Upgrade to SI Premium - Free Trial

Spruce Biosciences, Inc. (SPRB) PT Lowered to $230 at Oppenheimer

May 27, 2026 5:50 AM
(Updated - May 27, 2026 5:50 AM EDT)

Oppenheimer analyst Leland Gershell lowered the price target on Spruce Biosciences ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change